Pharmaceutical market: systematic offensive on all fronts
The volume of the global pharmaceutical market for 12 months – by October 2011
Weekly Pharmacy www.apteka.ua
based on the materials of IMS Health Incorporated
The global pharmaceutical market is steadily growing. By October 2011, the total sales volume on it reached 550.3 billion US dollars (according to the MAT – Moving annual total; table). Recall that as of September 2011, this figure was $ 547.8 billion.
The maximum contribution to the total volume of the global pharmaceutical market is provided by the USA. And the pharmaceutical markets of Venezuela and Argentina demonstrate the highest dynamics of sales volume.
In the pharmacotherapeutic structure of the world pharmaceutical market, the leader among the groups of the ATS classification of the 3rd level by October 2011 was consistently drugs of the C10A group "Lipid-lowering drugs, monocomponent". On the 2nd place is group A02B "Means for the treatment of peptic ulcer and gastroesophageal reflux disease"; on the 3rd and 4th - N05A "Antipsychotics" and N06A "Antidepressants". Group C09C "Simple angiotensin II antagonist drugs" closes the top 5.
By October 2011, Liprimar®/Lipitor® (atorvastatin) was traditionally the leader in the global pharmaceutical market in terms of sales in monetary terms. The 2nd, 3rd and 4th lines were taken by Plavix®/Plavix® (clopidogrel), Nexium®/Nexium® (esomeprazole) and Seretide®/Seretide® (fluticasone + salmeterol), respectively. Crestor®/Crestor® (rosuvastatin) is in the 5th position.
The top 5 corporations in terms of sales in monetary terms in the global pharmaceutical market also demonstrates enviable stability relative to previous periods. For 12 months – by October 2011 – it was headed by Pfizer Corporation; Novartis took 2nd place, AstraZeneca, Merck &Co. and GlaxoSmithKline took 3rd, 4th and 5th places, respectively.
Total sales of drugs on the main pharmaceutical markets for 12 months – by October 2011.
– indicating the percentage increase compared to the same period of the previous yearRegion/Country
| Pharmaceutical market volume, | billion US dollars∆ compared to |
November 2009– October 2010North America: |
|
249,8 |
3% | |
| USA* |
229,9 |
3% |
| Canada |
19,9 |
1% |
| Europe: Top 5 |
112,7 |
— |
| Germany |
38,4 |
2% |
| France |
29,3 |
— |
| Italy |
16,3 |
1% |
| Spain |
14,4 |
4% |
| Great Britain |
14,3 |
1% |
| Japan** |
98,2 |
6% |
| China |
38,3 |
18% |
| Latin America: Top 4 |
40,0 |
18% |
| Brazil |
21,5 |
19% |
| Mexico |
8,4 |
4% |
| Venezuela |
5,2 |
33% |
| Argentina |
4,8 |
29% |
| Australia/New Zealand |
11,3 |
6% |
| Total550,3 |
*Sales in pharmacies, grocery stores and through postal shipments are included.
**The data on sales volume in the Japanese market includes the sales volume of the hospital segment.
Portal "Eternal youth" http://vechnayamolodost.ru
13.01.2012